TY - JOUR
T1 - MiR-195, miR-455-3p and miR-10a* are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
AU - Ujifuku, Kenta
AU - Mitsutake, Norisato
AU - Takakura, Shu
AU - Matsuse, Michiko
AU - Saenko, Vladimir
AU - Suzuki, Keiji
AU - Hayashi, Kentaro
AU - Matsuo, Takayuki
AU - Kamada, Kensaku
AU - Nagata, Izumi
AU - Yamashita, Shunichi
N1 - Funding Information:
We thank Hiroko Kawasaki and Kazuto Miyazaki, students of Nagasaki University School of Medicine, for their contributions to the analysis of MGMT expression. This work was supported in part by Global COE Program and in part by Grant-in-Aid for Scientific Research (#21890192) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We have nothing to disclose in terms of financial support or relationships that may pose a conflict of interest.
PY - 2010/10
Y1 - 2010/10
N2 - To identify microRNAs (miRNAs) specifically involved in the acquisition of temozolomide (TMZ) resistance in glioblastoma multiforme (GBM), we first established a resistant variant, U251R cells from TMZ-sensitive GBM cell line, U251MG. We then performed a comprehensive analysis of miRNA expressions in U251R and parental cells using miRNA microarrays. miR-195, miR-455-3p and miR-10a* were the three most up-regulated miRNAs in the resistant cells. To investigate the functional role of these miRNAs in TMZ resistance, U251R cells were transfected with miRNA inhibitors consisting of DNA/LNA hybrid oligonucleotides. Suppression of miR-455-3p or miR-10a* had no effect on cell growth, but showed modest cell killing effect in the presence of TMZ. On the other hand, knockdown of miR-195 alone displayed moderate cell killing effect, and combination with TMZ strongly enhanced the effect. In addition, using in silico analysis combined with cDNA microarray experiment, we present possible mRNA targets of these miRNAs. In conclusion, our findings suggest that those miRNAs may play a role in acquired TMZ resistance and could be a novel target for recurrent GBM treatment.
AB - To identify microRNAs (miRNAs) specifically involved in the acquisition of temozolomide (TMZ) resistance in glioblastoma multiforme (GBM), we first established a resistant variant, U251R cells from TMZ-sensitive GBM cell line, U251MG. We then performed a comprehensive analysis of miRNA expressions in U251R and parental cells using miRNA microarrays. miR-195, miR-455-3p and miR-10a* were the three most up-regulated miRNAs in the resistant cells. To investigate the functional role of these miRNAs in TMZ resistance, U251R cells were transfected with miRNA inhibitors consisting of DNA/LNA hybrid oligonucleotides. Suppression of miR-455-3p or miR-10a* had no effect on cell growth, but showed modest cell killing effect in the presence of TMZ. On the other hand, knockdown of miR-195 alone displayed moderate cell killing effect, and combination with TMZ strongly enhanced the effect. In addition, using in silico analysis combined with cDNA microarray experiment, we present possible mRNA targets of these miRNAs. In conclusion, our findings suggest that those miRNAs may play a role in acquired TMZ resistance and could be a novel target for recurrent GBM treatment.
UR - http://www.scopus.com/inward/record.url?scp=77955282214&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77955282214&partnerID=8YFLogxK
U2 - 10.1016/j.canlet.2010.04.013
DO - 10.1016/j.canlet.2010.04.013
M3 - Article
C2 - 20444541
AN - SCOPUS:77955282214
SN - 0304-3835
VL - 296
SP - 241
EP - 248
JO - Cancer Letters
JF - Cancer Letters
IS - 2
ER -